Global health-tech major Medtronic has launched its Adaptive Deep Brain Stimulation (aDBS) system in India to improve the quality of life of patients living with Parkinson’s disease.

India accounts for 10% of the global Parkinson's disease (PD) burden, a progressive neurological condition that can affect how a person moves and functions in everyday life. While movement-related challenges are often the most visible, the condition can also influence other aspects of daily living, including communication, sleep, and overall well‑being. 

What is the aDBS system

Medtronic’s aDBS technology is an improvement over existing treatment options like Deep Brain Stimulation, which involve manual adjustment of stimulation levels throughout the day, usually managed by patients or caregivers. aDBS, which uses USFDA approved BrainSense technology, is designed to adapt real time to changes in a patient’s condition or medication needs—helping deliver more consistent symptom management.

 aDBS will automatically adjust therapy based on changes in brain signals or patient activity. By responding in real time, it aims to provide more consistent symptom control, minimize side effects, and help extend the life of the implanted device’s battery, Medtronic states.

 “We are extremely proud to introduce this advanced technology in India, where Parkinson’s disease is an increasingly significant healthcare concern. Our mission has always been to alleviate pain, restore health, and extend life, and the introduction of this system reflects our continued commitment to that mission. This milestone not only reaffirms our dedication to addressing the growing burden of Parkinson’s disease but also strengthens our leadership in bringing cutting-edge healthcare technologies to India to ultimately improve patients’ quality of life”, Prateek Tiwari, Senior Director, Neuroscience & Specialty therapies, Medtronic India says.

 Patients considering deep brain stimulation (DBS) typically begin by consulting a Movement Disorder Specialist, usually a neurologist, who evaluates whether their condition may benefit from this therapy. DBS follows a coordinated, team-based approach, with patients often referred to a comprehensive DBS clinic or neurosurgery board for further assessment. If considered suitable, a Functional Neurosurgeon—specially trained to perform the procedure—works alongside the care team to implant and program the device.

The introduction of the aDBS system comes at a critical time as India is expected to witness a significant rise in Parkinson’s disease cases—projected to become the second-highest globally within the next five years.